Kurita, M., Mashiko, H., Rai, M., Kumasaka, T., Kouno, Si., Niwa, Si. and Nakahata, N. (2002) Lithium Chloride at a Therapeutic Concentration Reduces Ca2+ Response in Protein Kinase C Down-Regulated Human Astrocytoma Cells. European Journal of Pharmacology, 442, 17-22.
http://dx.doi.org/10.1016/S0014-2999(02)01491-7

has been cited by the following article:

• TITLE: Effects of Lithium and Valproic Acid on the Production of Brain-Derived Neurotrophic Factor in Astrocytoma

  AUTHORS: Koji Ohtomo, Satoshi Nishino, Masatake Kurita, Hirobumi Mashiko, Shin-ichi Niwa

  KEYWORDS: BDNF, Bipolar Disorder, Lithium, PLCγ, TrkB, Valproic Acid

  JOURNAL NAME: Open Journal of Psychiatry, Vol.4 No.3, July 22, 2014

  ABSTRACT: No systematic investigation considering BDNF and its receptor TrkB has been conducted on the effects of mood-stabilizing drugs. We therefore decided to quantify BDNF production and the expression of TrkB-T1 receptor and PLCγ in astrocytoma. 1321N human astrocytoma cells were grown to a sufficient quantity in 5% fetal calf serum (FCS). The mood-stabilizing drugs Li and VPA were added to the therapeutic concentrations of 1 mM and 600 μM, respectively. The production of BDNF was determined by an enzyme-linked immunosorbent assay. The expressions of TrkB-T1 and PLCγ were determined by Western blot. The production of BDNF was significantly higher on Day 7 in the VPA samples (P γ expression did not change. Li and VPA seem differently affect BDNF production and TrkB-T1 (BDNF receptor) expression.